Dual-light defined in situ oral mucosal lesion therapy through a mode switchable anti-bacterial and anti-inflammatory mucoadhesive hydrogel

ZPTA-G/HMA can treat oral mucosal lesions by in situ anchoring to wet mucosa surface for hemostasis and the production of ROS for anti-bacteria under GL irradiation, as well as by enhanced anti-inflammation for promoting healing with NIR irradiation.